NewslettersHematopoiesis News Therapeutic Drug Monitoring of Imatinib – How Far Are We in the Leukemia Setting? By Noshin Noorjahan - February 20, 2024 0 The authors summarize different antileukemic treatment indications for tyrosine kinase inhibitors with focus on imatinib and its pharmacokinetic/-dynamic properties. [Expert Review of Clinical Pharmacology] Abstract